Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Axsome Therapeutics, Inc. - Common Stock
(NQ:
AXSM
)
105.07
+0.72 (+0.69%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 23, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Axsome Therapeutics, Inc. - Common Stock
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
21
22
Next >
Axsome Therapeutics's Return On Capital Employed Insights
November 30, 2022
Via
Benzinga
Struggling Axsome Stock Could Bounce Back on Drug Trial Success
November 30, 2022
Axsome Pharmaceuticals may be struggling to get out of the red but the success of two very recent drug trials could quickly change all of that.
Via
MarketBeat
Exposures
Product Safety
Analyst Ratings for Axsome Therapeutics
November 29, 2022
Via
Benzinga
FedEx To Rally Over 25%? Here Are 10 Other Price Target Changes For Tuesday
November 29, 2022
Keybanc lowered Salesforce, Inc. (NYSE: CRM) price target from $210 to $200. . Keybanc analyst Michael Turits maintained an Overweight rating on the stock. Salesforce shares gained 0.5% to $154.45 in...
Via
Benzinga
Tesla, Apple, Anavex, Axsome, Pinduoduo: Why These 5 Stocks Are Drawing Investors' Attention Today
November 28, 2022
Major Wall Street indices closed over 1% lower on Monday after protests in China against COVID-zero policies led to supply chain concerns.
Via
Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $13,000 Today
November 28, 2022
Via
Benzinga
Is Axsome Therapeutics Stock a Buy Now?
November 11, 2022
The company seems to be coming into its own.
Via
The Motley Fool
Dow Tumbles 450 Points; S&P 500 Falls 1.5%
November 28, 2022
U.S. stocks traded lower toward the end of trading amid protests over COVID-19 restrictions in China. The Dow Jones dropped more than 450 points on Monday.
Via
Benzinga
10 Things to Know as Tesla Revamps Model 3 With Project ‘Highland’
November 28, 2022
Recent reports claim that Tesla (TSLA) is planning to revamp the Model 3 under the secret "Highland" project and we have the details!
Via
InvestorPlace
Why Taboola Shares Are Trading Higher By Around 53%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
November 28, 2022
Gainers Taboola.com Ltd. (NASDAQ: TBLA) shares gained 52.5% to $2.8050 after the company announced it entered into a 30-year exclusive commercial agreement with Yahoo.
Via
Benzinga
Swvl Layoffs 2022: What to Know About the Latest SWVL Job Cuts
November 28, 2022
Swvl (SWVL) layoffs are here again as the micro-mobility company seeks to reduce costs by cutting more than 50% of its workforce.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
November 28, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Why Is Axsome Therapeutics (AXSM) Stock Up 32% Today?
November 28, 2022
Axsome Therapeutics (AXSM) stock is soaring higher on Monday after releasing positive results from a Phase 3 clinical trial.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
November 28, 2022
Via
Benzinga
Stocks Stumbling After Thanksgiving Week
November 28, 2022
The Dow Jones Industrial Average is extending its premarket losses, down 265 points at midday, as protests in China over the country's zero-Covid policy weigh on investor sentiment globally.
Via
Talk Markets
Dow Tumbles Over 200 Points; Axsome Therapeutics Shares Spike Higher
November 28, 2022
U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 200 points on Monday.
Via
Benzinga
US Stocks Start Week On Lower Note, Dow Drops Over 100 Points
November 28, 2022
U.S. stocks traded lower this morning, with the Dow Jones dropping more than 100 points on Monday.
Via
Benzinga
Axsome Therapeutics Unusual Options Activity
November 28, 2022
Someone with a lot of money to spend has taken a bullish stance on Axsome Therapeutics (NASDAQ:AXSM). And retail traders should know. We noticed this today when the big position showed up on publicly...
Via
Benzinga
Analyst Says Coinbase 'A Waste Of Time', Taylor Swift's Concert Fiasco Under DOJ Probe, Shopify Clocks Record Black Friday Sales: Top Stories Monday, Nov. 28
November 28, 2022
CNBC
Via
Benzinga
Biogen Dives On Reports Of Alzheimer's Death While Axsome Soars On Its Study Success
November 28, 2022
Biogen and Axsome stocks diverged Monday on news out of their Alzheimer's studies.
Via
Investor's Business Daily
Why Axsome Therapeutics Stock Is Soaring Today
November 28, 2022
Axsome Therapeutics Inc (NASDAQ: AXSM) shares are trading higher Monday morning after the company announced AXS-05 achieved its primary endpoint in the ACCORD Phase 3 trial in Alzheimer's disease...
Via
Benzinga
Axsome Therapeutics Investigational Drug Lowers Risk Of Agitation Relapse In Alzheimer's Patients
November 28, 2022
Axsome Therapeutics Inc's (NASDAQ: AXSM) AXS-05 substantially and statistically significantly delayed the time to relapse and prevented relapse of agitation in patients with Alzheimer's disease,...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 28, 2022
Via
Benzinga
Axsome Therapeutics Announces AXS-05 Achieves Primary Endpoint in the ACCORD Phase 3 Trial in Alzheimer’s Disease Agitation
November 28, 2022
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Want to Double Your Money? Buying These Stocks Could be a Genius Move
November 28, 2022
These stocks are undervalued considering their long-term growth potential.
Via
The Motley Fool
3 Growth Stocks to Buy That Could Skyrocket
November 28, 2022
The future looks promising for all three of these stocks.
Via
The Motley Fool
Prediction: This Growth Stock Could Double in 2023
November 24, 2022
The next year should be a busy one for this drugmaker.
Via
The Motley Fool
Axsome Therapeutics to Present at the 5th Annual Evercore ISI HealthCONx Conference
November 23, 2022
From
Axsome Therapeutics, Inc.
Via
GlobeNewswire
Got $500? 3 Growth Stocks to Buy That Could Double Your Money
November 20, 2022
Innovative products and services could keep these companies growing.
Via
The Motley Fool
These 3 Stocks Are Crushing the Market. Wall Street Thinks They Can Soar at Least 78% Higher.
November 18, 2022
The good times could keep on rolling for these big winners.
Via
The Motley Fool
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
21
22
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.